The objectives of this project are to provide essential biological substrates required for the study of genetic susceptibility to cancer. The offeror will initiate transformation of lymphocytes with Epstein-Barr virus in order to establish long term cultures of lymphoblasts. These cells will subsequently be used to extract DNA for genetic marker studies. DNA will also be extracted directly from the granulocytes and lymphocytes in whole blood, from cultured fibroblasts and tumors, and from fresh tumor material. The DNAs obtained from these assays will be used by investigators in the Environmental Epidemiology Branch (Family Studies Section) and the Clinical Epidemiology Branch (Clinical Genetics Section) in ongoing studies of cancer susceptibility due to genetic etiology.
| Shaw, G L; Falk, R T; Frame, J N et al. (1998) Genetic polymorphism of CYP2D6 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 7:215-9 |
| Shaw, G L; Weiffenbach, B; Falk, R T et al. (1997) Frequency of the variant allele CYP2D6(C) among North American Caucasian lung cancer patients and controls. Lung Cancer 17:61-8 |
| Shaw, G L; Falk, R T; Deslauriers, J et al. (1995) Debrisoquine metabolism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 4:41-8 |
| Kabat, G C; Morabia, A; Wynder, E L (1991) Comparison of smoking habits of blacks and whites in a case-control study. Am J Public Health 81:1483-6 |
| Kabat, G C; Wynder, E L (1987) Determinants of quitting smoking. Am J Public Health 77:1301-5 |
| Kabat, G C; Dieck, G S; Wynder, E L (1986) Bladder cancer in nonsmokers. Cancer 57:362-7 |
| Wynder, E L; Dieck, G S; Hall, N E (1986) Case-control study of decaffeinated coffee consumption and pancreatic cancer. Cancer Res 46:5360-3 |
